Evalar

---

title: "Evalar" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["companies-based-in-altai-krai", "pharmaceutical-companies-of-russia", "russian-brands"] description: "Russian dietary supplement company" topic_path: "geography/russia" source: "https://en.wikipedia.org/wiki/Evalar" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0

::summary Russian dietary supplement company ::

::data[format=table title="Infobox company"]

Field	Value
name	Evalar
logo	Evalar_logo.png
type	Closed joint-stock company
industry	Dietary supplements
predecessor	Altai Research Institute of Chemical Technology
founded	1991
founder	Larisa Prokopieva
defunct
hq_location_city	Biysk
hq_location_country	Russia
area_served
owner
num_employees_year
website
::

| name = Evalar | logo = Evalar_logo.png | type = Closed joint-stock company | industry = Dietary supplements | predecessor = Altai Research Institute of Chemical Technology | founded = 1991 | founder = Larisa Prokopieva | defunct = | hq_location_city = Biysk | hq_location_country = Russia | area_served = | key_people = | products = | owner = | num_employees = | num_employees_year = | parent = | website = ::figure[src="https://upload.wikimedia.org/wikipedia/commons/3/3e/EvalarOffice.JPG" caption="Evalar Company office"] ::

Evalar () is a Russian company producing dietary supplements. As of 2014, it held the largest share – 17% – of Russia's dietary supplements market.

History

The company was established in 1991 on the basis of Altai Research Institute of Chemical Technology. The original institute was a Soviet defence industry establishment producing gas coolers for the military. As the Soviet Union collapsed and the state enterprises were privatized, Larisa Prokopieva, who at the time headed one of the departments of the Institute, converted its facilities, originally to produce bubble gum, then cosmetics, and later, dietary supplements.

Criticism

Cardiologist Sergey Agarkov criticized the company for the following:

• The lack of information on high-quality evidence regarding the effectiveness of its products;
• Advertising dietary supplements in a way that presents them as pharmaceutical drugs;
• The absence of data on the amounts of active substances in the products.

Some of the company’s products are released in two forms (as a pharmaceutical drug and as a dietary supplement), which can mislead consumers.

In 2017, the British cosmetics manufacturer DR. ORGANIC LTD obtained a court ruling prohibiting Evalar JSC from using the brand name “Doctor Organic” in Russia.

In March 2019, Roszdravnadzor and the media accused dietary supplement manufacturers of attempting to brand their products with names that closely resemble those of pharmaceutical drugs.

References

References

1. (25 December 2014). "Деньги на траве: кто зарабатывает миллиарды на биодобавках. Фото {{!}} Бизнес {{!}} Forbes.ru".
2. (2018-02-15). "История предприятия".
3. "Прокопьева Лариса".
4. "Отзыв о компании кардиолога С.В.Агаркова".
5. Попов, Игорь. (2014-12-24). "Деньги на траве: кто зарабатывает миллиарды на биодобавках".
6. (2020-03-12). "«Афанасий» наносит ответный удар: «пивной» спор с «Хайнекеном» затягивается". Эксперт онлайн.
7. (2017-09-25). "Патентика защитила интересы английской компании «DR. ORGANIC LTD» в Суде по интеллектуальным правам, признавшем недействительным предоставление охраны товарному знаку «ДОКТОР ОРГАНИК» на имя ЗАО «ЭВАЛАР»". patentica.
8. (2020-03-02). "Граждане купились на добавку". Коммерсантъ.
9. (2 March 2020). "Росздравнадзор нашел причины популярности БАДов".
10. (2020-03-02). "Россияне лечатся БАДами. Без консультации с врачом это опасно".

::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::